Cargando…

Early Initiation of Corticosteroids Might be Harmful in Patients Hospitalized With COVID-19 Pneumonia: A Multicenter Propensity Score Analysis

Detalles Bibliográficos
Autores principales:	Pérez de Llano, Luis A., Golpe, Rafael, Pérez-Ortiz, Diego, Menéndez, Rosario, España Yandiola, Pedro P., Artaraz, Amaia, Zalacain, Rafael, Cilloniz, Catia, Torres, Antoni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SEPAR. Published by Elsevier España, S.L.U. 2022
Materias:	Scientific Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541830/ https://www.ncbi.nlm.nih.gov/pubmed/34720332 http://dx.doi.org/10.1016/j.arbres.2021.10.001

Ejemplares similares

Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria
por: Menéndez, Rosario, et al.
Publicado: (2022)

Diagnostic and therapeutic approach to occupational pneumonia
por: Yandiola, Pedro Pablo España, et al.
Publicado: (2022)

Impact of severe lymphopenia on the early prediction of clinical outcome in hospitalized patients with pneumococcal community-acquired pneumonia
por: Ruiz, Luis A., et al.
Publicado: (2023)

Factors Associated to Hospital Admission in a Care Protocol in COVID-19()
por: Golpe, Rafael, et al.
Publicado: (2020)

Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similarities
por: Serrano Fernández, Leyre, et al.
Publicado: (2022)

Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity-matched analysis
por: Cilloniz, Catia, et al.
Publicado: (2021)

Outcomes of Critically Ill Very Old Patients With Community-Acquired Pneumonia and Acute Respiratory Distress Syndrome
por: Cillóniz, Catia, et al.
Publicado: (2022)

Extracting relevant predictive variables for COVID-19 severity prognosis: An exhaustive comparison of feature selection techniques
por: Hayet-Otero, Miren, et al.
Publicado: (2023)

Effect of Corticosteroids on C-Reactive Protein in Patients with Severe Community-Acquired Pneumonia and High Inflammatory Response: The Effect of Lymphopenia
por: Torres, Antoni, et al.
Publicado: (2019)

Hyperglycemia in Acute Critically Ill COVID-19 Patients
por: Cilloniz, Catia, et al.
Publicado: (2023)

The Relevance of Comorbidities in the Persistence of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease
por: Figueira-Gonçalves, Juan Marco, et al.
Publicado: (2023)

Defining Community-Acquired Pneumonia as a Public Health Threat: Arguments in Favor from Spanish Investigators
por: Cillóniz, Catia, et al.
Publicado: (2020)

The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2021)

COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences
por: Tabernero, Eva, et al.
Publicado: (2021)

Age-related differences in management and outcomes in hospitalized healthy and well-functioning bacteremic pneumococcal pneumonia patients: a cohort study
por: Ruiz, Luis A., et al.
Publicado: (2017)

Corticosteroids for CAP, influenza and COVID-19: when, how and benefits or harm?
por: Martin-Loeches, Ignacio, et al.
Publicado: (2021)

Real-world corticosteroid use in severe pneumonia: a propensity-score-matched study
por: Ceccato, A., et al.
Publicado: (2021)

Epidemiology, etiology, and risk factors of bacterial pneumonia
por: Torres, Antoni, et al.
Publicado: (2015)

Steroid therapy and antiviral treatment in SARSCoV-2 pneumonia: clinical contexts and indications
por: Torres, Antoni, et al.
Publicado: (2022)

Host-targeted approaches to sepsis due to community-acquired pneumonia
por: Cilloniz, Catia, et al.
Publicado: (2022)

A Novel Approach to Temperature Profiling in Relation to Clinical Outcomes in Oncological Patients with Neutropenia
por: Cilloniz, Catia, et al.
Publicado: (2022)

Why patient representation might harm science?
por: Cassidy, Jim
Publicado: (2007)

Predicting treatment failure in patients with community acquired pneumonia: a case-control study
por: Martin-Loeches, Ignacio, et al.
Publicado: (2014)

Intrathecal corticosteroids might slow Alzheimer’s disease progression
por: Alisky, Joseph Martin
Publicado: (2008)

Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality
por: Bermejo-Martin, Jesus F., et al.
Publicado: (2017)

Editorial Commentary: Treatment of Asymptomatic Bacteriuria Might Be Harmful
por: Wagenlehner, Florian M. E., et al.
Publicado: (2015)

Subacute thyroiditis might be a complication triggered by SARS-CoV-2
por: Ruano, R., et al.
Publicado: (2021)

Subacute thyroiditis might be a complication triggered by SARS-CoV-2
por: Ruano, R., et al.
Publicado: (2021)

Multidrug Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors
por: Golpe, Rafael, et al.
Publicado: (2020)

Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors
por: Golpe, Rafael, et al.
Publicado: (2020)

Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial
por: Ceccato, Adrian, et al.
Publicado: (2017)

The Evolution and Distribution of Pneumococcal Serotypes in Adults Hospitalized With Community-Acquired Pneumonia in Spain Using a Serotype-Specific Urinary Antigen Detection Test: The CAPA Study, 2011–2018
por: Torres, Antoni, et al.
Publicado: (2021)

Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016–2020: The CAPA Study
por: Menéndez, Rosario, et al.
Publicado: (2023)

Characteristics and Management of Community-Acquired Pneumonia in the Era of Global Aging
por: Cillóniz, Catia, et al.
Publicado: (2018)

Pneumococcal pneumonia: differences according to blood culture results
por: Capelastegui, Alberto, et al.
Publicado: (2014)

Corticosteroids as Adjunctive Therapy in Severe Community-Acquired Pneumonia
por: Cillóniz, C., et al.
Publicado: (2016)

CORTICOSTEROIDS IN THE MANAGEMENT  OF PEDIATRIC EPILEPSIES
por: Prpić, Igor, et al.
Publicado: (2021)

Cytokine Activation Patterns and Biomarkers Are Influenced by Microorganisms in Community-Acquired Pneumonia
por: Menéndez, Rosario, et al.
Publicado: (2012)

Predicting 1-year mortality after hospitalization for community-acquired pneumonia
por: Uranga, Ane, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1832kbspb8ot69su7ar6d43vuq